Furthermore, high ARMC4 expression in CRC cells reduces NF-κB activity, cellular proliferation, anchorage-independent growth, and migratory ability in vitro and significantly decreases xenograft tumor growth in vivo, while shARMC4 knockdown has the opposite effect. Here, ODAD2 is linked to neoplasm.